Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3868)
All Articles published online
|
Jun 27, 2012 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lahbabi M, Aqodad N, Ibrahimi A, Lahlou M, Aqodad H. Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy. World J Hepatol 2012; 4(6): 196-198 [PMID: 22761971 DOI: 10.4254/wjh.v4.i6.196] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v4/i6/196.htm |
| Number | Citing Articles |
| 1 |
Pietro Gareri, Rosa P. Cerra, Laura Greco, Tania Falbo, Carlo Torchia, Giuseppe Coppolino, Alberto Castagna, Giovanni Ruotolo. Parenteral amiodarone-induced hepatoxicity: when being earnest is an added value. Gazzetta Medica Italiana Archivio per le Scienze Mediche 2019; 178(7-8) doi: 10.23736/S0393-3660.18.03868-8
|
| 2 |
Chia-Chi Chen, Chien-Chih Wu. Acute Hepatotoxicity of Intravenous Amiodarone. American Journal of Therapeutics 2016; 23(1): e260 doi: 10.1097/MJT.0000000000000149
|
| 3 |
Jana Ďuricová, Marcela Káňová, Ivana Kacířová. Amiodarone induced acute hepatotoxicity during intravenous application. Klinická farmakologie a farmacie 2018; 32(3): 34 doi: 10.36290/far.2018.031
|
| 4 |
Ji Hye Lee, Myug-Shin Kang, Tae-Hoon Kim, Dong Hee Shin, Rak Kyeong Choi, Su Jin Jung. A Case of Acute Hepatitis Associated with Intravenous Infusion Amiodarone in Patient with Atrial Fibrillation. Soonchunhyang Medical Science 2015; 21(2): 208 doi: 10.15746/sms.15.049
|
| 5 |
Joseph Offenbacher, Farnam Kazi, Niel Chen, Mohamed Mohamed, Jasmine Chacko, Nils Guttenplan, Vincent Nguyen. Immediate oral amiodarone re-challenge following the development of parenteral-induced acute liver toxicity. World Journal of Emergency Medicine 2021; 12(4): 321 doi: 10.5847/wjem.j.1920-8642.2021.04.012
|
| 6 |
Victorița Șorodoc, Lucia Indrei, Catinca Dobroghii, Andreea Asaftei, Alexandr Ceasovschih, Mihai Constantin, Cătălina Lionte, Bianca Codrina Morărașu, Alexandra-Diana Diaconu, Laurențiu Șorodoc. Amiodarone Therapy: Updated Practical Insights. Journal of Clinical Medicine 2024; 13(20): 6094 doi: 10.3390/jcm13206094
|
| 7 |
Jingrong Yang, Mengfan You, Jingxin Wang, Rongfei Sun, Lili Han, Xiaonan Liu, Kaibin Niu, Kaidi Xing, Juanping Sun, Wenge Su, Yifei Wang. Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1517616
|
| 8 |
Wai Pok Vernon Chan, Michelle A. Hieger. Low-Dose Intravenous Amiodarone-Induced Acute Hepatic Failure. American Journal of Therapeutics 2022; 29(3): e364 doi: 10.1097/MJT.0000000000001398
|
| 9 |
Ninad Ramesh Varkhede, Shalu Jhajra, Deepak Suresh Ahire, Saranjit Singh. Metabolite identification studies on amiodarone in in vitro (rat liver microsomes, rat and human liver S9 fractions) and in vivo (rat feces, urine, plasma) matrices by using liquid chromatography with high‐resolution mass spectrometry and multiple‐stage mass spectrometry: Characterization of the diquinone metabolite supposedly responsible for the drug's hepatotoxicity. Rapid Communications in Mass Spectrometry 2014; 28(4): 311 doi: 10.1002/rcm.6787
|
| 10 |
O.A. Diab, John Kamel, Ahmed Adel Abd-Elhamid. Predictors of intravenous amiodarone induced liver injury. The Egyptian Heart Journal 2017; 69(1): 45 doi: 10.1016/j.ehj.2016.05.001
|
| 11 |
Ana Lopes dos Santos, Margarida Lagarto, Cláudio Gouveia. A Rare Case of Intravenous Amiodarone Toxicity. Cureus 2022; doi: 10.7759/cureus.27958
|
| 12 |
Hui Shi, Ruizhen Chen, Minghui Li, Junbo Ge. Acute hepatotoxicity of intravenous amiodarone in a Becker muscular dystrophy patient with decompensated heart failing and ABCB4 gene mutation: as assessed for causality using the updated RUCAM. Journal of Cardiothoracic Surgery 2024; 19(1) doi: 10.1186/s13019-024-02869-7
|